📋 Tender Overview
The DAK-Gesundheit intends to conclude a non-exclusive discount agreement for the active ingredient allergen extract derived solely from meadow timothy grass pollen, ATC V01AA02, for the period from October 1, 2026, to October 31, 2027. This agreement allows health insurance companies and pharmaceutical companies to enter into framework discount contracts for medicines to be provided at the expense of statutory health insurance. The process will follow the relevant legal regulations for public procurement. Allergen extract from exclusively meadow timothy grass pollen, ATC V01AA02
